Introducing the new GLP-1 pen 🎉

ro.co · newsletter

Explore this email design and adapt it to your own brand. Review the copy, links, and offer before sending.

Email content

Ro.Co Icon

Introducing the new monthly pen | Get started

Most effective GLP-1. Half the price. | Get started

Same weight loss, more convenient than ever

Go on Ro today | Get started

*Based on highest dose of Zepbound in non-diabetics with obesity, or overweight and a weight-related medical condition, with diet and exercise (vs 3.1% with diet and exercise alone).

Ro advertising is independent of Lilly.

Important Safety Information

Zepbound KwikPen (tirzepatide) is a prescription medicine for weight management, paired with diet and exercise. Zepbound is tirzepatide and should not be used with other tirzepatide-containing products or other GLP-1s. Zepbound may cause serious side effects including possible thyroid tumors and thyroid cancer. Do not use Zepbound if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Zepbound may have other serious risks, including severe gastrointestinal disease, kidney injury, gallbladder disease, inflammation of the pancreas, severe allergic reactions, low blood sugar, and complications in patients with diabetic retinopathy. Zepbound may reduce the efficacy of oral birth control pills. Never share pens or needles. Tell your provider if you have a planned surgery. For more complete safety information, including Boxed Warning, visit ro.co/safety

Sexual health

Weight loss

Fertility

Hair loss

Skin care

Daily health

625 Avenue of the Americas, NY, NY 10011

Contact us

This email was sent to you because you indicated that you'd like to receive marketing and promotional emails from Ro. This email is intended for the recipient only.

Privacy Policy Terms of Service

No longer want to receive these emails?

Unsubscribe

Browse more email designs

Never let a signup go cold again.

Turn emails into revenue with Brew. No credit card, free credits to try.

Introducing the new GLP-1 pen 🎉

ro.co · newsletter

Explore this email design and adapt it to your own brand. Review the copy, links, and offer before sending.

Email content

Ro.Co Icon

Introducing the new monthly pen | Get started

Most effective GLP-1. Half the price. | Get started

Same weight loss, more convenient than ever

Go on Ro today | Get started

*Based on highest dose of Zepbound in non-diabetics with obesity, or overweight and a weight-related medical condition, with diet and exercise (vs 3.1% with diet and exercise alone).

Ro advertising is independent of Lilly.

Important Safety Information

Zepbound KwikPen (tirzepatide) is a prescription medicine for weight management, paired with diet and exercise. Zepbound is tirzepatide and should not be used with other tirzepatide-containing products or other GLP-1s. Zepbound may cause serious side effects including possible thyroid tumors and thyroid cancer. Do not use Zepbound if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Zepbound may have other serious risks, including severe gastrointestinal disease, kidney injury, gallbladder disease, inflammation of the pancreas, severe allergic reactions, low blood sugar, and complications in patients with diabetic retinopathy. Zepbound may reduce the efficacy of oral birth control pills. Never share pens or needles. Tell your provider if you have a planned surgery. For more complete safety information, including Boxed Warning, visit ro.co/safety

Sexual health

Weight loss

Fertility

Hair loss

Skin care

Daily health

625 Avenue of the Americas, NY, NY 10011

Contact us

This email was sent to you because you indicated that you'd like to receive marketing and promotional emails from Ro. This email is intended for the recipient only.

Privacy Policy Terms of Service

No longer want to receive these emails?

Unsubscribe

Browse more email designs